Tower Research Capital (TRC)’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Tower Research Capital (TRC)’s Portfolio FRBN Stock Details FRBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-599	Closed	-$6.57K	–	6358
2023 Q3	$6.57K	Buy	599 +301	+101%	+$3.27K	﹤0.01%	4582
2023 Q2	$3.2K	Buy	298 +183	+159%	+$1.94K	﹤0.01%	5098
2023 Q1	$1K	Buy	+115	New	+$1.2K	﹤0.01%	5703
2022 Q3	–	Sell	-10	Closed	–	–	6710
2022 Q2	$0	Hold	10	–	–	﹤0.01%	6753
2022 Q1	$0	Buy	+10	New	+$99	﹤0.01%	6809

Tower Research Capital (TRC)'s FRBN Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2023, closing a stake of 599 shares — an estimated $6.57K sold.

Tower Research Capital (TRC) first reported a position in FRBN in Q1 2022 and held it in 5 quarters. The position peaked at $6.57K in Q3 2023. 0 funds tracked by Wall St. Rank hold FRBN as of Q4 2023.

Tower Research Capital (TRC) reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 599 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $6.57K.
Tower Research Capital (TRC) first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
Tower Research Capital (TRC)'s Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $6.57K in Q3 2023.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.